ACCELERO:Ph1b/2 PF-08634404 Monotherapy or With Other AntiCancer Agents for RCC
Phase I/II Clinical Trial
AN INTERVENTIONAL PHASE 1B/2 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PF-08634404 MONOTHERAPY AND IN COMBINATION WITH OTHER ANTICANCER AGENTS IN ADULT PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC RENAL CELL CARCINOMA Code Number: C6461008
Participating Locations